European Society of Cardiology

European Society of Cardiology. Join us also on @ESC_Journals @ESCAdvocacy @ESCardioNews @ESC_President. #ESCCongress #ESCGuidelines #ESCTVToday #ESCDigital

[ESC Council on Stroke Chairperson @ESCStrokeChair]

Excellent Clinical Practice article in @NEJM on secondary prevention after ischemic #stroke.

A practical case vignette summarizing contemporary strategies for risk factor management and mechanism-specific prevention.

🔗 https://t.co/KH1KbJx2ZI
@JacopoImberti

[ACNAPPresident @ACNAPPresident]

❤️ Make an impact. Shape the future of cardiovascular care.

ACNAP is inviting applications for Committee Members: a unique opportunity to be actively involved in advancing cardiovascular nursing and allied professions.

By joining, you can:
🔹 Collaborate with an international, multidisciplinary community
🔹 Contribute to initiatives that shape practice and research
🔹 Develop your leadership and expand your professional network

A chance to move beyond participation and help drive meaningful change in cardiovascular care.

👉 Learn more and apply:

https://t.co/u9fxinK980

[ACVCPresident @ACVCPresident]

The final countdown of #AcuteCVDays is on ⏳
Week 5 challenges the often-asked question - can the contemporary management of #heartfailure prevent severe forms of #AHF and development of hashtag#CardShock? 🏥
And how should we proceed if this occurs?

This week's resources are done in collaboration with @HFA_President #HFA_ESC
Visit our website and enjoy
https://t.co/Px4sOr2ruc

You can start with an MCQ ⬇️

[ACVCPresident @ACVCPresident]

In a middle-aged pt w worsening HF, presenting with signs of congestion, low blood pressure and acute kidney injury, I’d initiate:

[ESC WG Thrombosis Chairperson @ESCWGThrombosis]

📢 Registration & abstract submission are now open for #HeartAndStroke2026 and #EuroThrombosis2026 in Prague (13–14 Nov)!

✅ All accepted abstracts will be published in the European Heart Journal Supplements.

🔗 https://t.co/7PPJDqth2R

#ESC #Thrombosis #Stroke #Cardiology

[HFAPresident @HFA_President]

🫀What drives the development of heart failure?

The new #HFA_ESC scientific statement highlights the broad spectrum of risk factors contributing to #HeartFailure including:
📍Cardiac-kidney-metabolic syndrome
📍Lifestyle factors
📍Cancer therapies
📍Female-specific risk factors
📍Environmental & socioeconomic determinants

Preventing HF requires a holistic approach focused on early identification & management of these interconnected risks

Read more in #EJHF @EJHFEiC : https://t.co/EqOZ6zRLG7

@escardio @MarcoMetra @m4ggiesimpson

[European Society of Cardiology @escardio]

Breakthroughs await! 🤗

Join Franz Weidinger and the other brilliant minds from across disciplines meeting at ESC Cardio-Oncology 2026 (19–20 June, Vienna, Austria).

It’s where you’ll learn and connect – and contribute to the solutions changing the future of cardio-oncology.

See you in Vienna at #ESCardioOnco26! https://t.co/DSUqGM0nSV

#cardioonc #cardioonco #oncology #radiology @ESCardioOnco

[European Society of Cardiology @escardio]

📺 Latest #ESCTVToday Episode👉 https://t.co/99tVj7R83o

Mitral annular disjunction (MAD) can be associated with life-threatening ventricular arrhythmias. In this new #ESCTVToday episode, Prof. @KristinaHaugaa discusses key strategies for managing patients with MAD.

#Cardiology #Echocardiography

[Dr. Chacón-Lozsán F .'. @franciscojlk]

Week 4 of #AcuteCVDays tackles a fascinating and increasingly relevant concept: “The inflamed heart.”💓

Not simply myocarditis. Not simply pericarditis. But an entire inflammatory cardiovascular continuum.

This matters because modern acute cardiovascular care is increasingly intersecting with:
• Autoimmune disease
• Systemic inflammation
• Immune checkpoint inhibitor toxicity
• Viral syndromes
• Post infectious inflammatory responses
• Inflammatory cardiomyopathies.

The heart is not an isolated pump. It is an immunologically active organ.

And inflammation changes everything:
• Arrhythmia risk
• Ventricular function
• Hemodynamics
• Thrombosis
• Long term remodeling
• Sudden cardiac death risk

One particularly important teaching point from this week: Endomyocardial biopsy is no longer viewed as an “academic only” tool.

In selected high risk presentations such as fulminant myocarditis, malignant arrhythmias, or rapidly progressive heart failure, tissue diagnosis may directly influence treatment decisions including immunosuppressive therapy.

Meanwhile, cardiac MRI has transformed non invasive diagnosis and risk stratification, particularly in stable patients with infarct like presentations and unobstructed coronaries.

The future of acute cardiac care may increasingly depend on combining: Imaging.
Immunology.
Molecular profiling.
Hemodynamics..
And precision phenotyping.

This is exactly why inflammatory cardiovascular syndromes are becoming central topics in cardiovascular intensive care education.

#ACVCDays #InflammatoryHeartDisease #Myocarditis #Pericarditis #CardiacMRI #CriticalCare #AcuteCardiovascularCare #ESC #CardioImmunology

References
Maisch, B., Gröschel, J., Heidecker, B., & Schulz Menger, J. (2026). ESC guidelines on myocarditis and pericarditis: First combined European guidelines for myocarditis and pericarditis. Herz. https://t.co/bclDpP45ZK

ESC Guidelines and Scientific Documents. https://t.co/90Gd1loapR

[Dr. Chacón-Lozsán F .'. @franciscojlk]

🤔A provocative ICU thought from Week 4 of #AcuteCVDays:
Sometimes the inflamed heart behaves more aggressively than the ischemic heart.🫠

Fulminant myocarditis may evolve within hours from:
• Mild chest pain
• Preserved LVEF
• Modest troponin elevation

…to refractory cardiogenic shock requiring:
• High dose vasopressors
• VA ECMO
• Mechanical ventilation
• Temporary pacing
• Mechanical circulatory support, and yet early diagnosis remains difficult because presentations are extraordinarily heterogeneous.

This week’s ACVC material highlights a critical concept: Myocarditis is not one disease. It is a spectrum.

Viral injury.
Immune mediated inflammation. Autoimmune overlap.
Toxic triggers.
Genetic susceptibility.
Inflammatory cardiomyopathies.

The real challenge is identifying which patient will deteriorate.

That is why contemporary management increasingly integrates:
• Clinical phenotype
• Arrhythmic burden
• Biomarkers
• Echocardiography
• Cardiac MRI
• Selective endomyocardial biopsy
• Hemodynamic profiling

The old paradigm viewed myocarditis mainly as a diagnosis of exclusion.

The modern paradigm treats it as an active inflammatory cardiovascular syndrome requiring early risk stratification, and perhaps the most important question: Are we recognizing fulminant myocarditis before circulatory collapse occurs?

Worth watching this week’s case discussions and quiz 🤓.

#ACVCDays #FulminantMyocarditis #VAECMO #ShockTeam #CriticalCareCardiology #HeartFailure #Inflammation #ESC

References
Arad, M. Trends in Cardiovascular Medicine. Advance online publication. https://t.co/YfayOZQaRn

Schaubroeck, H. (2026). ESC Acute CardioVascular Care 2026 Congress Presentation. https://t.co/CVc6aOeTsY

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🎓Ready to become a #CardioOncology leader?
Join the COOL Sessions at #ESC conference 2026 in Vienna 🇦🇹 and boost your publication strategy📚, educational skills🎤 and professional development 🚀
The future of cardio-oncology starts here! #COOL #ESCCardioOnc2026

[EAPCIPresident @EAPCIPresident]

A new EAPCI series of 5️⃣ Webinars on VHD is about to start

Episode 1️⃣ - Implementing VHD guidelines into real practice

Are there bottlenecks slowing down your VHD patient care? 🐌
🏎️ Join us and get up to speed on the latest strategies to deliver timely and effective care 🏁
From guideline highlights to streamlining VHD treatment pathways 🚀

📅 June 5th 2026
⏰ 6 PM CEST

Register for free 🔗 https://t.co/zbGf5rWN35
@escardio
#EAPCIWebinar #EAPCIfamily #EAPCIcommunity

[MIЯVΛƬ #IC ༄ ｡° @mirvatalasnag]

@escardio #CardioPractice #CardioTalk https://t.co/AFZZSdRGOQ

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

🎙️🚨New Podcast Alert!
How can cancer therapy impact blood pressure and vascular health?🩺❤️‍🩹
In our latest episode, Prof. Pietro Ameri 🇮🇹 and @LlamedoClara🇬🇧dive into “Hypertension and Vascular Toxicity in Cancer Therapy” #CardioOncology @ESC_Lavinia @TeresaLpezFdez1

[European Society of Cardiology @escardio]

#ESCardioOnco26 👇

Secure your place 👉https://t.co/c3U9MmTTOu

#cardioonc #cardioonco

[ESC Council of Cardio-Oncology Chairperson @ESCardioOnco]

Education, collaboration & implementation are key in #CardioOncology

📚#ESCardioOnco Certification Programme & Exam:
🔗 https://t.co/KBHjJokZFa

Join the growing global #cardiooncology community in Vienna this June:
🔗 https://t.co/P0o8QV30NH

@escardio

[HFAPresident @HFA_President]

📺 Now available on ESC TV: a special edition of the #HFA_ESC JournalClub, recorded live from #HeartFailure26

The discussion explores the SUBCUT HF II trial, role of subcutaneous furosemide in heart failure management.

🎙️ Host: @GTersalvi
🎙️ Co-host: @jozinetm
🎙️ Faculty: Profs @markcpetrie20 & @DukeHFDoc

📺 Watch here: https://t.co/naxBobeSb6

#HeartFailure #AcuteHeartFailure @escardio #HFAjournalclub #HFAyoung

[ACVCPresident @ACVCPresident]

The answer to this week's question is B.
The guidelines emphasize a clinical diagnosis supported by CMR as a cornerstone, replacing routine biopsy-first strategies. Endomyocardial biopsy is reserved for specific high-risk or unclear cases, not stable patients.

Check the resources on our website and stay tuned for Week 5 special
@escardio

https://t.co/Px4sOr2ruc

[EACVI President @EACVIPresident]

📢 #EACVI2026 Call for Abstracts closed yesterday with an incredible 833 submissions received from the global cardiovascular imaging community. Thank you to everyone who submitted!

🩺 Clinical case submissions are still open until 2 June, 12:00 CEST.

📍 Milan | 3–5 Dec 2026

@escardio @NAjmoneMarsan @rmanka_ @EchoSoliman @RFontesCarvalho @Ph_Bertrand @anatimoteo46040 @andgiannopmd @PezelT @RiccardoLiga7 @AnnaBaritussio @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503
#Cardiology #CVImaging #EchoFirst #whyCMR #CCT #CVNuclear #ThinkPet

[European Society of Cardiology @escardio]

#ESCAIsummit26 submission deadline extended to 2 June.

Share your abstract, technology or innovation with the people who can help move it forward, or bring a real-world challenge as a Hackathon topic.

Get expert feedback, build new connections & shape what comes next.

Finalise your submission: https://t.co/iE8mqiCqku

📅 12-13 November 2026, Basel, Switzerland

#CardiologyInnovation #DigitalHealth #AIinHealthcare #ESCDigital @fwasselbergs @SandyEngelh @BruiningNico

[ESC Council on Stroke Chairperson @ESCStrokeChair]

We're thrilled to host @drjohnm for the 1st episode of #ESC Cardio Talk - CoS Podcast🚀

Listen to the great debate on #LAAO: when, how, and in whom? on all your favourite apps

🖇️https://t.co/bBAiOjrxAM

@escardio @JacopoImberti @LiverpoolCCS @Fra_Vitali90